This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

. 2011 Aug 5;29(8):690-3.

doi: 10.1038/nbt.1936.

Biosimilars-why terminology matters

Martina Weise, Marie-Christine Bielsky, Karen De Smet, Falk Ehmann, Niklas Ekman, Gopalan Narayanan, Hans-Karl Heim, Esa Heinonen, Kowid Ho, Robin Thorpe, Camille Vleminckx, Meenu Wadhwa, Christian K Schneider

PMID: 21822237
DOI: 10.1038/nbt.1936

Biosimilars-why terminology matters

Martina Weise et al. Nat Biotechnol. 2011.

. 2011 Aug 5;29(8):690-3.

doi: 10.1038/nbt.1936.

Authors

Martina Weise, Marie-Christine Bielsky, Karen De Smet, Falk Ehmann, Niklas Ekman, Gopalan Narayanan, Hans-Karl Heim, Esa Heinonen, Kowid Ho, Robin Thorpe, Camille Vleminckx, Meenu Wadhwa, Christian K Schneider

PMID: 21822237
DOI: 10.1038/nbt.1936

No abstract available

PubMed Disclaimer

Similar articles

Demystifying biosimilars: development, regulation and clinical use.
Rugo HS, Rifkin RM, Declerck P, Bair AH, Morgan G. Rugo HS, et al. Future Oncol. 2019 Mar;15(7):777-790. doi: 10.2217/fon-2018-0680. Epub 2018 Nov 30. Future Oncol. 2019. PMID: 30500264
[Biosimilars - Potential, risks and open questions].
[No authors listed] [No authors listed] Dtsch Med Wochenschr. 2014 Jan;139(1-2):12-3. Dtsch Med Wochenschr. 2014. PMID: 24551883 German. No abstract available.
Biosimilar safety considerations in clinical practice.
Choy E, Jacobs IA. Choy E, et al. Semin Oncol. 2014 Feb;41 Suppl 1:S3-14. doi: 10.1053/j.seminoncol.2013.12.001. Epub 2013 Dec 6. Semin Oncol. 2014. PMID: 24560025
Current state of biosimilars in Mexico: The position of the Mexican College of Rheumatology, 2016.
Xibille D, Carrillo S, Huerta-Sil G, Hernández R, Limón L, Olvera-Soto G, Jara-Quezada LJ, Esquivel A, Pérez-Rodríguez M. Xibille D, et al. Reumatol Clin (Engl Ed). 2018 May-Jun;14(3):127-136. doi: 10.1016/j.reuma.2017.07.002. Epub 2017 Aug 12. Reumatol Clin (Engl Ed). 2018. PMID: 28807650 English, Spanish.
Biosimilars of biological drug therapies: regulatory, clinical and commercial considerations.
Dranitsaris G, Amir E, Dorward K. Dranitsaris G, et al. Drugs. 2011 Aug 20;71(12):1527-36. doi: 10.2165/11593730-000000000-00000. Drugs. 2011. PMID: 21861538 Review.

See all similar articles

Cited by

Potential of Biosimilars to Increase Access to Biologics: Considerations for Advanced Practice Providers in Oncology.
Tinsley SM, Grande C, Olson K, Plato L, Jacobs I. Tinsley SM, et al. J Adv Pract Oncol. 2018 Nov-Dec;9(7):699-716. Epub 2018 Nov 1. J Adv Pract Oncol. 2018. PMID: 31249718 Free PMC article. Review.
Comment on: "EU's new pharmacovigilance legislation: considerations for biosimilars".
Borg JJ, Serracino-Inglott A, Azzopardi LM, Schneider CK. Borg JJ, et al. Drug Saf. 2014 Feb;37(2):123-4. doi: 10.1007/s40264-013-0128-5. Drug Saf. 2014. PMID: 24338043 No abstract available.
Physicochemical and Functional Similarity Assessment Between Proposed Bevacizumab Biosimilar BAT1706 and Reference Bevacizumab.
Cao D, Deng C, Wang G, Mei X, Xie J, Liu Y, Liu Y, Yang Y, Li S, Liu C. Cao D, et al. Drugs R D. 2023 Sep;23(3):267-288. doi: 10.1007/s40268-023-00432-8. Epub 2023 Jul 22. Drugs R D. 2023. PMID: 37479945 Free PMC article.
From Basic Immunology to Clinical Practice: Bio-Originators versus Bio-Similars.
Liossis SC, Konstantopoulou GM. Liossis SC, et al. Mediterr J Rheumatol. 2019 May 31;30(Suppl 1):54-58. doi: 10.31138/mjr.30.1.54. eCollection 2019 Jun. Mediterr J Rheumatol. 2019. PMID: 32524078 Free PMC article. Review.
Randomized, active-controlled, comparative phase 3 efficacy and safety equivalence trial of Ovaleap® (recombinant human follicle-stimulating hormone) in infertile women using assisted reproduction technology (ART).
Strowitzki T, Kuczynski W, Mueller A, Bias P. Strowitzki T, et al. Reprod Biol Endocrinol. 2016 Jan 6;14:1. doi: 10.1186/s12958-015-0135-8. Reprod Biol Endocrinol. 2016. PMID: 26733057 Free PMC article. Clinical Trial.

See all "Cited by" articles

References

1. Nat Biotechnol. 2004 Nov;22(11):1383-91 - PubMed
1. Am J Health Syst Pharm. 2008 Jul 15;65(14 Suppl 6):S9-15 - PubMed
1. J Thromb Haemost. 2009 Jul;7(7):1218-21 - PubMed
1. Kidney Int. 2008 Dec;74(12):1617-22 - PubMed
1. NDT Plus. 2009 Jan;2(Suppl_1):i27-i36 - PubMed

Publication types

Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions

LinkOut - more resources

Full Text Sources
- Nature Publishing Group